AKT1 and neuroendocrine carcinoma: AKT signaling is hyper-activated in neuroendocrine cancers (50–52), and we found the similar results in our cell lines, where we showed that neuroendocrine cells maintain a higher AKT activation as compared to adenocarcinoma cells (Fig. S6L).